# Mark Daley

> Mark Daley is the Orlando-based founder and CEO of Conquest Research, a clinical-trial site network he started in 2018 after working in research administration at the University of Florida and as a clinical research coordinator at BioClinica Research. A 2023 majority investment from Reynolda Equity Partners gave Conquest a platform for expansion, followed by the additions of Sana Research in Virginia and NeuroTrials Research in Atlanta. His public record presents an operator focused on enrollment, clinical execution, local patient access and the careful work required to turn study protocols into usable data.

- **Role:** Founder and Chief Executive Officer at Conquest Research
- **Organizations:** Conquest Research, BioClinica Research, University of Florida
- **Education:** Bachelor of Science in Biology, University of Florida
- **Known for:** Founded Conquest Research in 2018 and developed it into a clinical-trial site network with six publicly listed locations across Florida, Virginia and Georgia., Secured a 2023 majority investment from Reynolda Equity Partners to support Conquest Research's next stage of growth., Led Conquest through the acquisitions of Sana Research and NeuroTrials Research.

## Career timeline

- **2011-2015** — Studied biology at the University of Florida.
- **Before 2018** — Worked in research administration at the University of Florida Cancer and Genetics Research Complex and served as a clinical research coordinator in BioClinica Research's neurology department.
- **2018** — Founded Conquest Research in Winter Park, Florida.
- **2023-09** — Reynolda Equity Partners acquired a majority interest in Conquest Research to support organic growth, new locations and selective acquisitions.
- **2025-04** — Conquest Research acquired Sana Research, extending the network into Northern Virginia.
- **2025-07** — Attended the Alzheimer's Association International Conference with Conquest medical director Dr. Malisa Agard.
- **2025-12** — Conquest Research acquired Atlanta-based NeuroTrials Research; the transaction was publicly announced in January 2026.

## Achievements

- Founded Conquest Research in 2018 and developed it into a clinical-trial site network with six publicly listed locations across Florida, Virginia and Georgia.
- Secured a 2023 majority investment from Reynolda Equity Partners to support Conquest Research's next stage of growth.
- Led Conquest through the acquisitions of Sana Research and NeuroTrials Research.
- Conquest reported that its first FDA inspection, prompted by high enrollment on a study, ended with no Form 483 observations and a recommendation of No Action Indicated.

## Latest updates

- **2026-01** — Conquest Research publicly announced its acquisition of NeuroTrials Research, expanding the network into Atlanta.
- **2025-07** — Daley attended AAIC 2025 with Conquest medical director Dr. Malisa Agard.
- **2025-04** — Conquest Research acquired Sana Research and expanded into the Washington, D.C. region.

## Links

- Website: https://conquestresearch.com
- LinkedIn: https://www.linkedin.com/in/mark-daley-5b210791
- Instagram: https://www.instagram.com/conquest_research/
- Facebook: https://www.facebook.com/conquestresearch/

---

Profile page: https://yespress.io/mark-daley
Published by YesPress — https://yespress.io
Last updated: 2026-08-27